Danish Medicines Council releases recommendations – mixed bag for Sanofi and BMS
Eight applications have been processed during the Danish Medicines Council’s March meeting, including submissions on indication expansions from Sanofi and Bristol Myers Squibb, both of which received both good and less-than-uplifting recommendations.
by albert rønning-andersson, translated by daniel pedersen
On Wednesday last week, pharmaceutical firms Sanofi and Bristol Myers Squibb received a mixed bag of recommendations from Danish Medicines Council.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
.jpg)
CHMP approves 5 new drugs in March
For subscribers
